Treatment of pityriasis amiantacea with infliximab
Pham, R.K.; Chan, C.S.; Hsu, S.
Dermatology Online Journal 15(12): 13
2009
ISSN/ISBN: 1087-2108 PMID: 20040263 Document Number: 633376
Document emailed within 1 workday
Related Documents
Veller Fornasa, C.; De Zio, A.; Serratì, E.; Bersani, G.; Peserico, A. 1983: Microbiologic study of 76 patients with pityriasis sicca, pityriasis steatoides and pseudotinea amiantacea Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 118(5): 277-279Ayanlowo, O.O.; Olowoyo, O.O.; Akinkugbe, A.O.; Adelekan, F.A.; Ahamneze, N.C. 2014: Pityriasis amiantacea: a case report Nigerian Postgraduate Medical Journal 21(2): 196-198
Shah, A.; Shenoi, S.D.; Srinivas, C.R. 1995: Peg - 200 with 12% salicylic acid ointment in pityriasis amiantacea Indian Journal of Dermatology Venereology and Leprology 61(4): 238
Batten, T.L.; White, M.I.; Gregory, D.W. 1993: Scanning electron microscopy of scales from pityriasis amiantacea Acta Dermato-Venereologica 73(5): 376-377
Mattox, A.R.; Chappell, J.A.; Hurley, M.Y. 2013: New-onset vitiligo during long-term, stable infliximab treatment of pityriasis rubra pilaris Journal of Drugs in Dermatology: Jdd 12(2): 217-219
Udayashankar, C.; Nath, A.K.; Anuradha, P. 2013: Extensive Darier's disease with pityriasis amiantacea, alopecia and congenital facial nerve palsy Dermatology Online Journal 19(6): 18574
Braun-Falco, O. 1980: Treatment of pityriasis sicca of the scalp Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 31(12): 678
Cobo-Ibáñez, T.; Muñoz-Fernández, S.; Hidalgo-Barrero, V.; Martín-Mola, E. 2006: Medium-long term treatment with infliximab and methotrexate in posterior and/or chronic uveitis refractory to conventional treatment Medicina Clinica 126(1): 34-35
Gregoriou, S.; Argyriou, G.; Christofidou, E.; Vranou, A.; Rigopoulos, D. 2007: Treatment of pityriasis rubra pilaris with pimecrolimus cream 1% Journal of Drugs in Dermatology: Jdd 6(3): 340-342
Rasi, A.; Tajziehchi, L.; Savabi-Nasab, S. 2008: Oral erythromycin is ineffective in the treatment of pityriasis rosea Journal of Drugs in Dermatology: Jdd 7(1): 35-38
Pietrzak, A.; Chodorowska, G.; Jazienicka, I.; Junak-Bojarska, A.; Roliński, J. 2003: New development in the treatment of psoriasis--infliximab Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 58(1): 322-327
Abdelmoula, L.C.; Yahia, C.B.H.; Testouri, N.; Tekaya, R.; Ben M'barek, R.; Chaabouni, L.; Zouari, R. 2008: Treatment of reactive arthritis with infliximab La Tunisie Medicale 86(12): 1095-1097
Larrègue, M.; Coutard Vant, F.; Bressieux, J.M.; Fusade, T.; Crampon, P. 1990: Acute pityriasis rubra pilaris in children. Treatment with etretinate (Tigason) Annales de Dermatologie et de Venereologie 117(11): 825-826
Kaskel, P.; Grundmann-Kollmann, M.; Schiller, P.I.; Krähn, G.; Pillekamp, H.; Peter, R.U.; Kerscher, M. 1999: Bath-PUVA as a treatment for Pityriasis rubra pilaris provoked by ultraviolet B British Journal of Dermatology 140(4): 769-770
Bravo, E.A.; Carrion, L.; Paucar, S.M.; Mendoza, R.; Rivera, C. 2014: Successful treatment of pityriasis rubra pilaris with adalimumab - case report Dermatology Online Journal 20(4): 22374
Bobbitt, S.A.; Klaus, E.M.; Stringer, E.; Chowdhury, D.; Finlayson, L. 2016: Treatment of refractory pyoderma gangrenosum with infliximab in a 17-month-old boy Dermatology Online Journal 22(4)
Sri, J.C.; Tsai, C.L.; Deng, A.; Gaspari, A.A. 2007: Osteomyelitis occurring during infliximab treatment of severe psoriasis Journal of Drugs in Dermatology: Jdd 6(2): 207-210
Chan, J.L.; Graves, M.S.; Cockerell, C.J.; Pandya, A.G. 2010: Rapid improvement of pyoderma gangrenosum after treatment with infliximab Journal of Drugs in Dermatology: Jdd 9(6): 702-704
Zheng, J.-J.; Wang, Y.-M.; Zhu, F.; Gu, W.; Xing, Y.-C.; Zhou, C.-L.; Shen, B.-W. 2009: A study of efficiacy of infliximab treatment for Crohn's disease Zhonghua Nei Ke Za Zhi 48(11): 922-925
Tak, P.P. 2005: Effects of infliximab treatment on rheumatoid synovial tissue Journal of Rheumatology. Supplement 74: 31-34